Trials / Terminated
TerminatedNCT01093118
A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis
A Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TMI-358 in the Treatment of Distal Subungual Onychomycosis of the Toenail
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Talima Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if a local treatment is effective for the treatment of toenail fungus (distal subungual onychomycosis).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TMI-358 | Micro implant monthly x 3 |
| DRUG | MMI-467 | Micro implant monthly x 3 |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-04-01
- First posted
- 2010-03-25
- Last updated
- 2011-01-17
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01093118. Inclusion in this directory is not an endorsement.